1. Home
  2. ESPR vs NGS Comparison

ESPR vs NGS Comparison

Compare ESPR & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo Natural Gas Services Group Inc.

NGS

Natural Gas Services Group Inc.

HOLD

Current Price

$43.79

Market Cap

475.1M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
NGS
Founded
2008
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
475.1M
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
ESPR
NGS
Price
$3.14
$43.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$8.75
$40.67
AVG Volume (30 Days)
17.2M
82.6K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
1.08%
EPS Growth
60.71
14.60
EPS
N/A
0.53
Revenue
$403,135,000.00
$172,315,000.00
Revenue This Year
N/A
$15.05
Revenue Next Year
$12.81
$9.52
P/E Ratio
N/A
$82.83
Revenue Growth
21.31
9.94
52 Week Low
$0.76
$22.72
52 Week High
$4.18
$44.12

Technical Indicators

Market Signals
Indicator
ESPR
NGS
Relative Strength Index (RSI) 70.94 67.80
Support Level $2.37 $32.52
Resistance Level $3.15 N/A
Average True Range (ATR) 0.03 1.59
MACD 0.04 0.29
Stochastic Oscillator 96.51 92.00

Price Performance

Historical Comparison
ESPR
NGS

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About NGS Natural Gas Services Group Inc.

Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.

Share on Social Networks: